Asston Pharmaceuticals IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Wed Jul 09 2025
Asston Pharmaceuticals IPO GMP is ₹10 as of 9th July 2025. It is a book building IPO of 22.41 lakh shares and entirely a fresh issue worth ₹27.56 crore. The issue will be listed on BSE and SME on its tentative listing date, 16th July 2025. The price band for the Asston Pharmaceuticals IPO is set between ₹115 and ₹123 per share. Retail investors can bid for a minimum 2 lots of 2,000 shares worth ₹2,46,000.
Asston Pharmaceuticals IPO GMP Grey Market Premium
As of 9th July 2025, Asston Pharmaceuticals IPO GMP stands at ₹10 per share. Thus, the estimated listing price would be ₹133 (123+10). This indicates that the estimated listing gain in this IPO could be 8.13%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Asston Pharmaceuticals IPO GMP updates.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 09-07-2025 | ₹123 | ₹10 | ₹133 | 8.13% |
| 08-07-2025 | ₹123 | ₹10 | ₹133 | 8.13% |
| 07-07-2025 | ₹123 | ₹10 | ₹133 | 8.13% |
| 06-07-2025 | ₹123 | ₹10 | ₹133 | 8.13% |
| 05-07-2025 | ₹123 | ₹10 | ₹133 | 8.13% |
| 04-07-2025 | ₹123 | ₹0 | ₹123 | 0.00% |
| 03-07-2025 | ₹123 | ₹0 | ₹123 | 0.00% |
| 02-07-2025 | ₹123 | ₹0 | ₹123 | 0.00% |
| 01-07-2025 | ₹123 | ₹0 | ₹123 | 0.00% |
Asston Pharmaceuticals IPO Details
| IPO Open Date | 9th July 2025 |
| IPO Close Date | 11th July 2025 |
| IPO Allotment Date | 14th July 2025 |
| Refund Initiation | 15th July 2025 |
| Issue Size | 22,41,000 shares (worth ₹27.56 crore) |
| Face Value | ₹10 per share |
| Lot Size | 1,000 shares |
| Issue Price Band | ₹115 to ₹123 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE & SME |
| Listing Date | 16th July 2025 |
Explanation
Asston Pharmaceuticals IPO: Asston Pharmaceuticals Limited has declared a price band of ₹115 and ₹124 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,000 shares worth ₹2,46,000. The face value of Asston Pharmaceuticals Ltd.’s share is ₹10 per share. The shares of Asston Pharmaceuticals Limited will be listed on BSE & SME on its tentative listing day, 16th July 2025. Scroll down to check GMP updates and Asston Pharmaceuticals IPO reviews.
Objectives of Asston Pharmaceuticals IPO
The primary aim of the Asston Pharmaceuticals IPO is to raise ₹27.56 crores. On the other hand, Asston Pharmaceuticals Limited has decided to utilise these funds in different prospects. Explore some of the secondary objectives for the Asston Pharmaceuticals IPO.
- To meet capital expenditure on the acquisition of machinery in the manufacturing facility.
- To meet the general corporate purposes.
- To fund the incremental working capital requirements of the company.
- To repay certain borrowings.
Asston Pharmaceuticals IPO Registrar
Maashitla Securities Private Limited is the registrar of the Asston Pharmaceuticals IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Asston Pharmaceuticals IPO allotment and refund, you can contact Maashitla Securities Private Limited at investor.ipo@maashitla.com or +91-11-45121795-96.
Asston Pharmaceuticals IPO Review
The Asston Pharmaceuticals IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Asston Pharmaceuticals Limited’s revenue soared by 61.67% from ₹15.84 crores in March 2024 to ₹25.61 crores in March 2025. Moreover, the company’s PAT increased by 218.38% from ₹1.36 crores to ₹4.33 crores. Investors can analyse other relevant factors and make a decision accordingly.
Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Asston Pharmaceuticals IPO or not.
Asston Pharmaceuticals Limited Technicals
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 17.83 |
| EPS (Earnings Per Share) | 6.90 |
| RoNW | 40.36% |
| ROCE | 51.25% |
| ROE | 50.56% |
| EBITDA Margin | 24.60% |
| Price to Book Value | 12.07 |
| Market Capitalisation | ₹104.70 cr. |
The PE ratio of Asston Pharmaceuticals Limited shares is 17.83, and its Earnings Per Share (EPS) stands at 6.90. Thus, the Asston Pharmaceuticals IPO can potentially deliver gains on its tentative listing date, 16th July 2025.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Asston Pharmaceuticals Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 17.83 | 13.20 |
| EPS | 6.90 | 9.32 |
Asston Pharmaceuticals Limited Peer Comparison
| Company Name | Revenue (in cr.) | PE Ratio | Face Value (in Rs) | EPS | RoNW (in %) |
| Asston Pharmaceuticals Limited | 25.61 | 17.83 | 10 | 6.90 | 40.36% |
| Shelter Pharma Limited | 40.03 | 6.70 | 10 | 6.26 | 16.94% |
| Trident Lifeline Limited | 46.71 | 25.29 | 10 | 11.35 | 19.85% |
| BAFNA Pharmaceuticals Limited | 156.00 | 51.38 | 10 | 1.76 | 4.89% |
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Also Read : Travel Food Services IPO GMP: Day 1 IPO Live Updates
FAQs on Asston Pharmaceuticals IPO
What is Asston Pharmaceuticals IPO GMP?
Ans. Currently, on 9th July 2025, Asston Pharmaceuticals IPO GMP (Grey Market Premium) stands at ₹10 (8.13% up). This indicates that the estimated listing price could be ₹133 per share.
What is the issue price of Asston Pharmaceuticals IPO?
Ans. Asston Pharmaceuticals IPO price band has been set between ₹115 and ₹123 per share. Retail investors can apply for a minimum of 2 lots consisting of 2,000 shares worth ₹2,46,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth ₹3,69,000.
Who is the registrar of the Asston Pharmaceuticals IPO?
Ans. Maashitla Securities Private Limited is the registrar of the Asston Pharmaceuticals IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Asston Pharmaceuticals IPO allotment and refund, you can contact Maashitla Securities Private Limited at investor.ipo@maashitla.com or +91-11-45121795-96.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Asston Pharmaceuticals IPO, download the Asston Pharmaceuticals IPO RHP and Asston Pharmaceuticals IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Recent Articles
Zepto IPO Details: Everything You Should Know About
CFF Fluid Control IPO GMP & Review: Apply or Avoid?
Asston Pharmaceuticals IPO GMP & Review: Apply or Avoid?
GLEN Industries IPO GMP: Day 1 IPO Live Updates
JSW Cement IPO GMP & Review: Apply or Avoid?
Flipkart IPO Details: Everything You Should Know About
GLEN Industries IPO GMP & Review: Apply or Avoid?
Smarten Power Systems IPO GMP: Day 1 IPO Live Updates
Chemkart India IPO GMP: Day 1 IPO Live Updates
